info@seagull-health.com
SeagullHealth
语言:
search
new
How to Use ExtraSuperTadarise
504
Article source: Seagull Pharmacy
Oct 13, 2025

ExtraSuperTadarise is a combination preparation, whose main ingredients include Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).

How to Use ExtraSuperTadarise

Routine Dosage and Administration

Recommended dose: Usually 1 tablet taken orally daily; the dose is adjusted according to individual response. A common specification contains 20 mg Tadalafil + 60 mg Dapoxetine.

Dosage form and strength: Film-coated tablets, which must be swallowed whole and should not be broken or chewed.

Administration requirements: It is recommended to take the medication 30–60 minutes before sexual activity, either with food or on an empty stomach.

Pre-Treatment Evaluation

Cardiovascular assessment: Ensure there is no risk of severe heart disease or hypotension.

Drug interaction check: Avoid concurrent use with nitrate medications or strong CYP3A4 inhibitors.

Medication Precautions

Need for sexual stimulation: Sexual stimulation is required to trigger the drug’s effect.

Effect of food: A high-fat diet may delay the absorption of Dapoxetine but does not affect the efficacy of Tadalafil.

Precautions for ExtraSuperTadarise Administration

Contraindications

Nitrate medications: Concurrent use with any form of nitrates is strictly prohibited, as it may lead to severe hypotension.

Severe cardiovascular diseases: Such as recent myocardial infarction, unstable angina pectoris, etc.

Adverse Reactions Requiring Vigilance

Cardiovascular events: Symptoms such as chest pain and palpitations require immediate medical attention.

Neurological symptoms: Dapoxetine may cause dizziness or syncope; avoid driving or operating machinery.

Patients with Hepatic Impairment

Mild to moderate hepatic impairment: No dose adjustment is needed, but close monitoring is required.

Severe hepatic impairment: Avoid use, as there is insufficient data on safety and efficacy.

Patients with Renal Impairment

Moderate renal impairment: The maximum dose should not exceed 10 mg Tadalafil, with administration interval of 48 hours.

Severe renal impairment or dialysis patients: Use is prohibited.

Elderly Patients (≥ 65 Years Old)

Caution is required; the initial dose is recommended to be halved, and blood pressure and heart rate should be monitored.

Patients on Concomitant Medications

CYP3A4 inhibitors: For example, ketoconazole and ritonavir. The dose needs to be limited to 10 mg Tadalafil, with administration no more than once every 72 hours.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What Are the Side Effects of ExtraSuperTadarise?
ExtraSuperTadarise is a combination preparation whose main ingredients include Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE). ...
Indications for Etrasimod
Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator developed by ViiV Healthcare, which was first approved in the United States in 2023. As a novel oral medication for the treatment of ulc...
Indications for Fostemsavir
Fostemsavir is a novel antiretroviral drug. As an HIV-1 gp120-directed attachment inhibitor, it provides an important treatment option for patients with multiply drug-resistant HIV-1 infection.Indicat...
How to Use Fostemsavir
Fostemsavir is an HIV-1 gp120-directed attachment inhibitor indicated for the treatment of adult patients with HIV-1 infection that is resistant to multiple drugs.How to Use FostemsavirDosing RegimenD...
How Effective Is ExtraSuperTadarise in Treatment?
ExtraSuperTadarise is a combination preparation, with its main ingredients including Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation ...
How Effective is ExtraSuperTadarise?
ExtraSuperTadarise is a compound preparation whose main ingredients include Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).How ...
Precautions for Taking ExtraSuperTadarise
ExtraSuperTadarise is a compound preparation whose main ingredients are Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).Precauti...
Indications for ExtraSuperTadarise
ExtraSuperTadarise is a compound preparation mainly used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE). As an enhanced formulation of Cialis (Tadalafil), it combin...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved